FDC
Venkatesh Nallamchetty is an experienced business leader with significant expertise in the pharmaceutical and biotech sectors. Currently serving as Business Head-UK at FDC Limited since August 2022, Venkatesh previously held the position of Country Director at Fabtech Technologies UK from January 2017 to August 2022, focusing on technology licensing and turnkey projects. Prior to that, Venkatesh was Commercial Director UK at Lupin for nearly eleven years, where responsibilities included overall P&L and portfolio management, and also served as Director of Business Development Europe. Venkatesh began their career at Ethypharm as Head of Exports & Licensing, working in high technology environments. Academic qualifications include an MBA from SVKM's Narsee Monjee Institute of Management Studies, a Diploma in EXIM Management from the University of Mumbai, and a BSc in Microbiology from the University of Mumbai.
This person is not in any offices
FDC
FDC Limited is a pharmaceutical company. The Company is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its therapeutic areas of focus include anti-infectives, gastrointestinals, ophthalmologicals, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology and analgesics. It has a range of functional foods and beverages. Its active pharmaceuticals ingredients (APIs) produced cover a range of therapeutic categories, such as Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate. Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm. It has multi-location manufacturing facilities for APIs, as well as finished dosage forms. Its facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh.